This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a ...

The company is advancing its Phase I/II trial and exploring accelerated approval pathways in the US and Europe.

A global survey explores the impact of geographic atrophy (GA) on quality of life, revealing similar challenges for ...